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Abstract
This study aims to evaluate the etiology of pediatric sensorineural hearing loss (SNHL). A total of 423 children with SNHL were
evaluated, with the focus on the determination of causative genetic and acquired etiologies of uni- and bilateral SNHL in relation
to age at diagnosis and severity of the hearing loss. We found that a stepwise diagnostic approach comprising of imaging, genetic,
and/or pediatric evaluation identified a cause for SNHL in 67% of the children. The most common causative finding in children
with bilateral SNHL was causative gene variants (26%), and in children with unilateral SNHL, a structural anomaly of the
temporal bone (27%). The probability of finding an etiologic diagnosis is significantly higher in children under the age of 1 year
and children with profound SNHL.
Conclusions: With our stepwise diagnostic approach, we found a diagnostic yield of 67%. Bilateral SNHL often has a genetic
cause, whereas in unilateral SNHL structural abnormalities of the labyrinth are the dominant etiologic factor. The diagnostic yield
is associated with the age at detection and severity of hearing loss: the highest proportion of causative abnormalities is found in
children with a young age at detection or a profound hearing loss.
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What is Known:
• Congenital sensorineural hearing loss is one of the most common congenital disorders
• Determination of the cause is important for adequate management and prognosis and may include radiology, serology, and DNA analysis
What is New:
•Using a stepwise diagnostic approach, causative abnormalities are found in 67% both in uni- and bilateral SNHL, with the highest diagnostic yield in
very young children and those suffering from profound hearing loss
• Bilateral SNHL often has a genetic cause, whereas in unilateral SNHL structural abnormalities of the labyrinth are the dominant etiologic factor
Keywords Bilateral hearing loss . Children . Etiology . SNHL . Unilateral hearing loss
Abbreviation
AABR Automated auditory brainstem response
AC Audiology center
AD Autosomal dominant
AR Autosomal recessive
CDS Center of diagnostics of SNHL
CHARGE Coloboma, heart defect, atresia choanae, retard-
ed growth and development, genital and ear
abnormality
CMV Cytomegalovirus
CT Computed tomography
EVA Enlarged vestibular aqueduct
IAC Internal auditory canal
MR Magnetic resonance imaging
NGS Next-generation sequencing
PCR Polymerase chain reaction
PTA Pure-tone audiometry
SNHL Sensory neural hearing loss
TORCH Toxoplasmosis, other, rubella, cytomegalovirus
(CMV), and herpes infections
USNHL Unilateral sensory neural hearing loss
VUmc VU University Medical Center
WES Whole-exome sequencing
Introduction
The prevalence of congenital sensorineural hearing loss (SNHL)
is one to two per thousand live births, making it one of the most
common congenital disorders [21, 25]. Early diagnosis and in-
tervention is important in the acquisition of hearing, speech, and
linguistic skills, thereby contributing to the positive development
of the child [12]. Newborn hearing screening programs have
been introduced, facilitating early identification of hearing-
impaired children and enabling timely intervention by means
of counseling, support, hearing aids, or cochlear implantation
in severe cases [19, 28]. The current newborn hearing screening
program in Netherlands was introduced from 2002 to 2006.
Newborn screening programs have also sparked the interest
in the causes of pediatric hearing loss. Although SNHL is
generally irreversible, an adequate etiological evaluation
may be important for a number of reasons: prognostication
of the progression of the hearing loss of the affected ear and
of the unaffected ear in unilateral hearing loss, identification
of associated physical conditions, identification of other fam-
ily members at risk, adequate intervention if possible, and
accurate counseling of the patients and their parents [2].
Imaging, DNA tests, and screening for congenital infections
and metabolic diseases are frequently performed in the etiolog-
ical evaluation of SNHL. It is estimated that a genetic factor is
responsible for about 50% of all congenital SNHL cases, of
which 70% are estimated to be non-syndromic and 30% are
syndromic [17, 21, 25]. An acquired factor is found in 25%
of the congenital SNHL cases [17]. These include congenital
infections (TORCH: toxoplasmosis, others, rubella, cytomega-
lovirus, and herpes simplex viruses) and risk factors such as
hypoxia during birth, hyperbilirubinemia, prematurity, and a
stay at a neonatal intensive care unit (NICU) longer than 5 days.
Despite etiological evaluation, the etiology of SNHL is reported
to remain unknown in 25–45% of the cases [17, 21, 25].
In this study, the outcome of a stepwise diagnostic approach
towards an etiological diagnosis in children with unilateral or
bilateral SNHL was evaluated, with a focus on the influence of
determinants such as degree and laterality of hearing loss and
the age of diagnosis on the outcome of etiological diagnostics.
Materials and methods
For the full material and methods, see Electronic
Supplementary Material.
Upon parental consent, children diagnosed with bilateral or
unilateral SNHL between January 2006 until January 2016
were offered etiological diagnostics by a dedicated multidis-
ciplinary team consisting of otologists, audiologists, pediatri-
cians, clinical geneticists, neuroradiologists and, if indicated,
neurologists or ophthalmologists at the VU University
Medical Center (VUmc) Amsterdam, Netherlands. Patients
were referred by audiology centers, general practitioners,
and otorhinolaryngologists. The majority of children were re-
ferred directly after the diagnosis of the hearing loss, but in
some cases the need for etiological evaluation arises later in
life, and consequently the referral takes place at an older age.
The protocols for the diagnostic evaluation of the etiology of
SNHL in children are based on Dutch guidelines and the
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experience of the CDS team [24], and include radiology, pedi-
atric and genetic evaluation. The outcome of radiology alone in
children with SNHL has been described in more detail else-
where [22, 23]. During the 10-year period reviewed in this study,
some diagnostic protocols were altered or added to the diagnos-
tic battery due to technological development or the evolving
understanding of SNHL in children. Technical improvements
have also taken place, for instance single-gene testing has been
largely replaced by whole-exome sequencing (WES), andWES
protocols have been improved since their introduction.
Audiometric tests
The audiometric evaluation was performed by the referring
Audiology Center or by the VUmc Audiology Center. The
audiometric evaluation consisted of pure tone audiometry
(PTA) if possible, auditory brainstem response using clicks
(ABR), or both.
The degree of hearing loss was determined on the first avail-
able audiometric test and summarized by an average threshold
at 500, 1000, 2000 and 4000 Hz on PTA or the estimated hear-
ing threshold around 3 kHz on ABR. Children were diagnosed
with bilateral SNHL if the sensorineural hearing threshold at the
best hearing ear was 30 dB or more. Asymmetric bilateral
SNHL was defined as 1 or more frequencies with greater than
a 30 dB difference, 2 or more frequencies with greater than a 15
dB difference in threshold or 3 or more frequencies with greater
than a 10 dB difference in threshold between the 2 ears (10,22).
Unilateral SNHLwas defined as a hearing threshold at the worst
hearing ear of 30 dB or more, and a hearing threshold of 20 dB
or less at the contralateral ear. Hearing loss was categorized as a
slight impairment (26-40 dB), moderate impairment (41-60
dB), severe impairment (61-80 dB) and profound impairment
(81 dB or greater) according to the classification of the World
Health Organization (WHO) [10] . A patients’ hearing loss was
graded according to the worst hearing side. In case of mixed
type hearing loss, the inclusion and consecutive analyses were
based on the sensorineural component only. Patients with pure
conductive hearing loss were excluded from this study.
Age
The age at detection was defined as the age at which the hearing
loss was first diagnosed by the Audiology Center, either by
ABR or PTA. Patients were categorized in 4 age groups: 0-1
year old, 1-6 years old, 6-12 years old and 12-18 years old.
Evaluation etiological work-up
Patient charts were reviewed for demographic data, audiometry,
and the results of dysmorphologic, pediatric, ophthalmologic,
and neurologic evaluation. Furthermore, the use and results of
imaging, molecular genetic testing, and laboratory tests were
reviewed. Imaging consisted of computed tomography (CT) of
the temporal bone and/or MR imaging of the inner ear,
cerebellopontine angle, and brain. The decision to obtain imag-
ing and the choice of the imaging modality was individualized
per patient and made by the multidisciplinary team. Molecular
genetic testing consisted at first of Sanger sequencing of one or
several single genes (usuallyGJB2, other genes based on clinical
suspicion), 201 children in our population underwent this type of
genetic testing. Whole-exome-sequencing (WES) became avail-
able in a diagnostic setting in 2013. WES targeting a panel of
hearing loss–related geneswas performed in 204 children [29]. A
congenital CMV infection was detected with polymerase chain
reaction (PCR) using the dried blood spots on Guthrie cards,
which are preserved for 5 years after birth in Netherlands. After
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Fig. 1 Pie charts illustrating the distribution of etiological causes of a
unilateral and b bilateral sensorineural hearing loss
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this period, Guthrie cards are destroyed and reliable detection of
congenital CMV is no longer possible. During the period
reviewed in this study, an unrelated nationwide study into the
occurrence of congenital CMV infections in children with con-
genital SNHL in Netherlands was taking place [10]. Some chil-
dren were already evaluated for the occurrence of congenital
CMV by this study before presentation for etiologic diagnosis
of SNHL, in these cases, the CMV status as determinedwas used
for the analysis in this study, and testing was not repeated at our
center. Additional tests were performed when indicated by the
multidisciplinary team and included metabolic screening and
DNA testing for copy number variations by single-nucleotide
polymorphism (SNP) array, urine screening for hematuria and
proteinuria (in case of childhood onset hearing loss in boys),
ECG, and evaluation of congenital infections other than CMV.
The etiology of SNHL was divided into different diagnos-
tic categories: genetic, suspected genetic, structural anomalies,
acquired, miscellaneous, and unknown (Fig. 1). A genetic
cause was established if it was confirmed with DNA testing
[29]. The SNHL was considered to be of Bsuspected genetic^
origin if there was a strong suspicion of syndromic SNHL
because of a patients’ dysmorphic features or comorbidities,
a positive family history for SNHL, a gene variant of un-
known pathogenicity in a gene known to be associated with
hearing loss, or in some cases with a single autosomal reces-
sive pathogenic gene variant and a specific phenotype associ-
ated with that gene. A diagnosis was categorized as Bstructural
anomaly^ if a causative abnormality was found on imaging,
and no further genetic or syndromic diagnosis could be
established. Acquired causes included congenital TORCH in-
fections, meningitis, hyperbilirubinemia requiring exchange
transfusion, asphyxia, neonatal intensive care stay longer than
5 days, prematurity, trauma, ototoxic drugs, and others. These
risk factors were deemed causative of SNHL after exclusion
of other possible causes.
Results
Clinical characteristics
A total of 498 children with SNHL were retrospectively eval-
uated. Seventy-five children were excluded from the study
because further evaluation was not performed at their parent’s
request, the hearing loss was not of sensorineural origin, or the
sensorineural component did not exceed 30 dB. A total of 423
children were reviewed, 239 males and 184 females. Age at
detection of hearing loss ranged from 1 week to 16.9 years
(median age of 0.9 year). The mean age of children with
bilateral SNHL was 0.7 years old, and the mean age of chil-
dren with USNHLwas 3.3 years old. One hundred and ninety-
seven children were diagnosed with hearing loss before the
age of six months (47%). They were referred directly after
newborn hearing screening. Two hundred and twenty-six chil-
dren (53%) were referred at an older age.
Source of referral
Two hundred fifty-one (59%) children were referred by audi-
ology centers, 99 (23%) by otolaryngologists, 24 (6%) by
other medical specialists including pediatricians, 18 (4%) chil-
dren by NICUs, 20 (5%) by child health and care service, and
11 (3%) by general practitioners.
Hearing loss
Bilateral SNHL was diagnosed in 300 patients (71%) and
unilateral SNHL in 123 children (29%). The hearing loss
was most frequently profound in nature, both in uni- and bi-
lateral SNHL (48% and 39%, respectively) (Table 1). The
hearing loss was detected by automated auditory brainstem
response (AABR) in 242 children (57%), at a mean age of
9 months old. The remaining children underwent pure-tone
audiometry (PTA).
Etiological work-up
The etiological evaluation was performed using a stepwise
protocol in 67% of the children with USNHL and in 61% of
the children with bilateral SNHL (Fig. 2). Reasons to deviate
from the protocol were medical indications (including menin-
gitis, neurodevelopment disorders, and syndromic features), a
cochlear implant procedure, or parental request.
Etiology
The etiology of the SNHL could be established in 67% of
the children. The distribution of etiologic diagnoses is pre-
sented in Fig. 1. Among the children with an established
etiology, the cause was most frequently genetic (n = 87,
31%) or acquired (n = 75, 26%) (Supplementary
Table 3).The probability of identifying an etiologic diagno-
sis is significantly higher in the youngest age group (74%
vs. 60%, p < 0.01). We also found a significantly higher
diagnostic yield in the most severe hearing loss category
(p = 0.01). As suspected, there was a significant association
between age and the level of hearing loss (p = 0.03), i.e.,
the most severe hearing loss category is overrepresented in
the youngest age group. Using a likelihood ratio test, the
level of hearing loss was found to be of significant added
value to a logistic regression model that included age only
(p = 0.01), and vice versa (p = 0.04). This suggests that
both severity of hearing loss and age are independent prog-
nosticators for finding an etiologic diagnosis.
The probability of identifying a cause for SNHL did not
differ between children with uni- and bilateral hearing loss
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(67% and 67%, respectively; p = 0.92). Nevertheless, the dis-
tribution of the etiologies was different for these two groups: a
genetic etiology was found more frequently in the children
with bilateral SNHL (27%), whereas a structural temporal
bone abnormality was detected more often in children with
USNHL (25%) (Table 2 A and B).
Genetics
A clinical evaluation by the geneticist was completed in 330/
423 children. In 307 of these children, a DNA analysis was
performed; 57/123 (46%) children with USNHL and 250/300
(83%) with bilateral SNHL. Reasons for genetic testing in
Table 1 Demographics and
clinical characteristics of 423
children who underwent
etiological evaluation for uni- or
bilateral SNHL
Characteristics Total (n/%) Unilateral (n/%) Bilateral (n/%)
Number of patients 423 (100%) 123 (29%) 300 (71%)
Sex n (M/F) M 239
F 184
(57%)
(43%)
M 67
F 56
(54%)
(46%)
M 172
F 128
(57%)
(43%)
Hearing loss category*
1 Slight (26–40 dB) 64 (15%) 19 (15%) 45 (15%)
2 Moderate (41–60 dB) 114 (27%) 22 (18%) 92 (31%)
3 Severe (61–80 dB)
4 Profound (80 dB or greater)
69
176
(16%)
(42%)
23
59
(19%)
(48%)
46
117
(15%)
(39%)
Age at diagnosis (median/range) years 0.9 (0–1.9) 3.3 (0–15.8) 0.7 (0–16.9)
Age at diagnosis is the age at which the hearing loss was first diagnosed by an Audiology Center
*Hearing loss categories according to the WHO classification [11]
Fig. 2 Diagnostic yield (n/n (%)) of the stepwise etiological diagnostic
approach of SNHL in children. Not all children underwent all diagnostic
modalities or the same diagnostic work-up: if a causative abnormalitywas
identified in the first diagnostic step, additional diagnostics were not
always deemed necessary. SNHL, sensorineural hearing loss; CT,
computed tomography; MR, magnetic resonance imaging; ECG,
electrocardiogram; CMV diagnostics, congenital cytomegalovirus DNA
testing by PCR
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children with USNHL included abnormalities found on CT
and/or MR imaging, suspicion of syndromic SNHL, or a
strong positive family history of genetic SNHL. A genetic
abnormality associated with SNHL was identified in 87/307
children overall (28%). The diagnostic yield of genetic eval-
uation is higher in children with bilateral SNHL compared
with children with USNHL (52% vs. 33% of the tested chil-
dren). Genetic evaluation also revealed a significant higher
proportion of genetic causes in the youngest age group (56%
vs. 39%, p < 0.01). In contrast, the probability of finding a
genetic cause was comparable between the different hear-
ing loss categories (p = 0.07). Over time, the protocols for
genetic evaluation have changed, from single-gene testing
to WES. Especially since the introduction of WES, the di-
agnostic yield has increased (in this study from 26 to 36%)
and will probably increase even more in the future due to
improved protocols.
Of the children with a confirmed genetic cause (n = 87) for
SNHL, 47% presented with syndromic etiology and 53%with
non-syndromic etiology (Table 3; Supplementary Table 1).
The most frequent genetic cause was a mutation in the GJB2
gene (27 patients, 30%), encoding Connexin 26. The most
common syndromic cause was Usher syndrome (6 patients,
7%), followed by Stickler syndrome (5 patients, 6%). Ten
patients (10%) were identified with Pendred syndrome.
Children with a suspected genetic cause (n = 70), presented
in 43%with a positive family history for SNHL, 39% presented
with a suspected syndrome associated with SNHL, and 18%
had a gene mutation of unknown pathogenicity, or a single
heterozygous variant in a gene (predominantly in the
SLC26A4 gene) known to cause SNHL with autosomal reces-
sive inheritance. Fourteen (20%) of these children had USNHL
and 56 (80%) bilateral SNHL (Supplementary Table 2).
Imaging
Radiologic imaging was performed in 321 children (76%), of
which 112 children had USNHL and 209 had bilateral SNHL.
Ninety children (28%) underwent CTas a single modality, 110
children (34%) underwent MR as a single modality, and 122
children (38%) underwent both modalities. The overall prev-
alence of relevant findings on imaging was 38%. Of all iden-
tified abnormalities, 60% was located within the labyrinth,
15% in the cochlear nerve, and 25% in the brain. Detailed
description of the type of abnormality has been reported else-
where [22, 23].
Table 2 A. The etiology of SNHL in children in relation to age. B. Etiology of SNHL in relation to degree of hearing loss
A.
Etiology Unilateral Bilateral
n = 123 n = 300
Age (years old) Overall 0-1 1-6 6-12 12-18 Total 0-1 1-6 6-12 12-18 Total
Total 423 55 (45%) 38 (31%) 27 (22%) 3 (2%) 123 159 (53%) 86 (29%) 45 (15%) 10 (3%) 300
Genetic 87 6 - - 1 7 50 18 8 4 80
Suspected genetic 70 8 4 2 - 14 29 14 9 4 56
Structural 48 9 10 12 2 33 8 4 3 - 15
Acquired 85 13 10 3 - 26 32 13 4 - 49
Miscellaneous 4 3 - - - 3 1 - - - 1
Unknown 139 16 14 10 - 40 39 37 21 2 99
Age: Age at which the hearing loss was first diagnosed by an Audiology Center.
B.
Etiology Unilateral Bilateral
n = 123 n = 300
Degree of SNHL Overall 26-40 dB 41-60 dB 61-80 dB >81 dB Total 26-40 dB 41-60 dB 61-80 dB >81 dB Total
Total 423 19 (15%) 22 (18%) 23 (19%) 59 (48%) 123 45 (15%) 92 (31%) 46 (15%) 117 (39%) 300
Genetic 87 1 2 - 4 7 9 28 17 26 80
Suspected genetic 70 3 1 4 6 14 10 18 13 15 56
Structural 48 4 9 2 18 33 1 4 - 10 15
Acquired 85 1 1 6 18 26 5 8 2 34 49
Miscellaneous 4 2 - - 1 3 - - - 1 1
Unknown 139 8 9 11 12 40 20 34 14 31 99
Hearing loss categories according the WHO classification. SNHL: sensory neural hearing loss.
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The diagnostic yield of imaging is higher in children with
USNHL than in children with bilateral SNHL (48% vs. 32%).
Profound hearing loss is associated with the highest chance of
finding a radiological abnormality (p < 0.01). In contrast, the
probability of finding an abnormality with CTor MR imaging
was comparable between the different age groups (42% vs.
34%, p = 0.13).
Laboratory and other tests
Congenital CMV was diagnosed in a large proportion of the
tested patients (35/165; 21%). Two children had a negative
CMV PCR but clear and specific clinical signs andMR findings
associated with CMV infections, and were therefore diagnosed
as patients with congenital CMV by the pediatric neurologist.
Table 3 Genetic causes
confirmed by DNA analysis or
metabolic screening tests
Genetic Syndrome/disease Gene Total
(n)
Unilateral
(n)
Bilateral
(n)
87 6 81
Non-syndromic 46 2 44
AR DFNB1* GJB2/6 27 2 25
DFNB7/11 BSND7 1 – 1
DFNB8 TMPRSS3 1 – 1
DFNB9 OTOF 1 – 1
DFNB16 STRC 5 – 5
DFNB18 USH1C 1 – 1
DFNB22 OTOA 2 – 2
DFNB28 TRIOBP 1 – 1
AD DFNA1 DIAPH1 1 – 1
DFNA3 GJB2/6 2 – 2
DFNA4 MYH14 1 – 1
DFNA10 EYA4 2 – 2
DFNA22 MYO6 1 – 1
Syndromic 41 4 37
AR Brown-Vialetto-Van Laere
syndrome
SLC52A2 1 – 1
Chudley-McCullough
syndrome
GPSM2 1 – 1
DFNMYP syndrome** SLITRK6 1 – 1
Hurler syndrome*** IDUA 1 – 1
Niemann-Pick disease type B SMPD1 1 1 –
Pendred syndrome SLC26A4 10 – 10
Usher syndrome MYO7A,
USH2A
6 – 6
Walker-Warburg syndrome POMT1 1 – 1
AD Ayme-Gripp syndrome MAF 1 – 1
CHARGE CHD7 3 1 2
Primrose syndrome ZBTB20 1 – 1
Stickler syndrome COL9A1 5 – 5
Waardenburg syndrome PAX3, SOX10 2 1 1
Chromosomal Velo-cardio-facial syndrome – 1 – 1
Down syndrome – 3 1 2
X-linked Alport syndrome COL4A5 1 – 1
Hunter syndrome IDS 1 – 1
Turner syndrome X(q21) 1 – 1
AR, autosomal recessive; AD, autosomal dominant; CHARGE, coloboma, heart defect, atresia choanae, retarded
growth and development, genital and ear abnormality
* One patient was diagnosed with DFNB1 based on DNA confirmed DFNB1 diagnosis in a sibling with SNHL
**Deafness and myopia syndrome
***Hurler syndrome was established by metabolic screening test
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Twenty children with a congenital CMV infection had bilateral
SNHL (20/37; 54%) (Fig. 2). We identified a congenital CMV
infection in a significantly higher proportion of children with
USNHL compared with children with bilateral SNHL (37%
vs. 17%, p < 0.01). In children with a congenital CMVinfection,
the severity of the hearing loss is usually profound, milder hear-
ing loss was significantly less frequently observed (p < 0.01).
Metabolic screening tests were performed upon indication in
57/423 (13%) children. Three out of 423 (1%) patients had a
metabolic disorder (mucopolysaccharidosis type I (n = 1),
mucopolysaccharidosis type II (n = 1), and Niemann-Pick dis-
ease (n = 1). Urinalysis was performed in 19 (4%) children, one
of whom had an abnormality which contributed to the diagnosis
of Alport syndrome. An electrocardiogramwas performed in 53
(12%) children, in two patients an abnormality was identified
(in one case related to CHARGE syndrome and the other related
to the disease of Niemann-Pick). Ophthalmologic examination
was performed in 243 children (57%), of which 38 hadUSNHL
and 205 bilateral SNHL. Abnormalities were identified in 84
(35%) children. Twelve children (5%) had eye abnormalities
related with syndromic SNHL (i.e., retinitis pigmentosa and
coloboma) or congenital CMV infection (chorioretinitis). The
remaining children had refractive disorders or strabismus.
Discussion
Using a stepwise diagnostic approach, we could identify an
etiological diagnosis in 67% in children with uni- and bilateral
SNHL (Fig. 3). This diagnostic yield is comparable with pre-
vious reports (55–81%) [3, 4, 5, 13, 18, 26].
Unilateral vs. bilateral SNHL
The majority of children that were referred for etiological diag-
nostics suffered from bilateral SNHL (71%). Whereas, the
chance of identifying an etiological diagnosis is comparable
for USNHL and bilateral SNHL (67% vs. 67%), the distribution
of etiologies differs between both groups. The most frequent
etiology in children with USNHL was an isolated structural
anomaly of the temporal bone, while in children with bilateral
SNHL the most common cause was a genetic variant affecting
gene function (in short, variant) [20, 26].
Age and degree of hearing loss
The probability of finding an etiologic diagnosis is significantly
higher in children with profound SNHL [11, 26]. In the current
study, we also find a higher diagnostic yield in the youngest age
group, and both age and severity of hearing loss are independent
prognosticators for finding an etiologic diagnosis. However, the
diagnostic yield in older pediatric patients and patients with
milder hearing losses is still considerable (Table 2).
Imaging
CTand/or MR imaging was performed in 76% of the patients.
Imaging is an essential part of the etiologic analysis of
Fig. 3 Diagnostic flow chart for childrenwith both unilateral and bilateral
sensorineural hearing loss. The results of the first step will direct further
examination. Deviations from the protocol may be indicated by the
multidisciplinary team (i.e., family history, medical indications, or
cochlear implant procedure)
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USNHL because of the high prevalence of causative abnor-
malities that can be identified with radiology (38% in our
population). In agreement with previous reports, we find a
higher ratio of causative abnormalities in children with
USNHL (49%) compared with children with bilateral SNHL
(32%), indicating a higher diagnostic yield of imaging in chil-
dren with USNHL [3, 8, 15, 27]. Because of this, we recom-
mend to perform radiology as the first diagnostic step in pa-
tients with USNHL, and genetic evaluation as the first step in
bilateral SNHL. We recommend performing CT imaging as
the first modality of choice in USNHL, followed by MR im-
aging if CT results are negative (Supplemental Fig. 1), and
MR imaging in bilateral SNHL [22, 23]. By performing the
modality with the highest diagnostic yield first, additional
diagnostics may be avoided, minimizing the impact on the
patient and reducing costs.
Genetic evaluation
We found that the diagnostic yield of DNA testing is consid-
erably higher in children with bilateral SNHL than in children
with USNHL (27% vs. 5%). In agreement with previous re-
ports, variants of the GJB2 gene were the most prevalent ge-
netic cause (30%) [1, 8, 11, 13, 14, 16, 20, 26]. We found an
equal distribution of syndromic and non-syndromic genetic
etiologies, in contrast with the reported dominance of non-
syndromic diagnoses [1, 18, 25]. The Pendred spectrum was
the most common syndromic diagnosis in our cohort (10%).
While this is in accordance with some previous reports, others
find thatWaardenburg or Usher syndromes are more prevalent
[16, 25].
Congenital CMV infection
Congenital CMV infection is by far the most prevalent ac-
quired cause of congenital SNHL in this study, an observation
that is in line with previous reports [6, 12]. In our study pop-
ulation, congenital CMV infection was found in 9% of all
included children, and in 21% of children tested for CMV.
With the growing recognition of congenital CMV infections
as a cause of SNHL, CMV tests are nowadays performed in all
children that present with SNHL, but in the first years of this
study, this evaluation was not standard protocol. In addition, a
neonatal screening program for congenital CMV infections
has not yet been introduced in Netherlands, and the diagnosis
relies on CMV PCR using the Guthrie card. As this is avail-
able until the age of 5 years in Netherlands, children that
present after the age of 5 cannot be reliably tested for congen-
ital CMV infections. The hearing loss of most of the children
with congenital CMV in this cohort was classified as pro-
found, which is in line with prior studies [7, 18]. We found
that the diagnostic yield of the screening for congenital CMV
infections is higher in children with USNHL than in children
with bilateral SNHL (37% vs. 17%). With the possible advent
of newborn screening programs for congenital CMV infec-
tions, the diagnosis of congenital CMV may become even
more prevalent [7, 10].
Limitations
Due to the stepwise approach towards the etiological diagno-
sis, not all children underwent the same etiological diagnos-
tics. In addition, deviations from the protocol were sometimes
indicated by the multidisciplinary team. Reasons to deviate
from the protocol were medical indications (e.g., meningitis),
a cochlear implant procedure or upon parental request. As a
consequence, radiology was performed more often in children
with unilateral SNHL, and genetic evaluation was performed
more frequently in children with bilateral SNHL. The diag-
nostic yield of these modalities can therefore not be reliably
compared between these two groups of children. If a cause
was found by the first diagnostic modality, an additional di-
agnostic test was not always performed, and an additional
cause for SNHL may have been missed in children with mul-
tiple etiologies. In our cohort, two children were identified
with multiple possible causes for SNHL: in one child, a co-
chlear nerve aplasia was found as well as aGJB2 gene variant,
in the other, a congenital CMVinfection was identified as well
as Down syndrome. Performing all etiological tests in all chil-
dren could possibly increase the detection rate of children
suffering from multiple etiologies; however, this should be
weighed against the additional costs and impact on all children
undergoing etiological evaluation for SNHL.
Conclusion and recommendations
The chance of identifying the cause of SNHL in children is
high. Using our stepwise diagnostic approach, we found a
diagnostic yield of 67%, both in children with uni- and bilat-
eral SNHL (Fig. 3). Bilateral SNHL often has a genetic cause,
whereas in unilateral SNHL, structural abnormalities of the
labyrinth are the dominant etiologic factor. Based on these
results we start the etiologic diagnostic work-up with genetic
evaluation in children with bilateral SNHL, and with radiolo-
gy in children with USNHL (Supplementary Fig. 1).
Congenital CMV infections are a cause for both uni- and bi-
lateral SNHL, and we recommend evaluation of congenital
CMV infections in all children that present with SNHL. The
highest proportion of causative abnormalities is found in chil-
dren younger than 1 year and in children suffering from pro-
found hearing loss. However, the diagnostic yield in older
pediatric patients and patients with milder hearing losses is
still considerable. We therefore offer etiological diagnostics
to all pediatric patients with SNHL exceeding 30 dB, irrespec-
tive of age or degree of hearing loss.
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